收藏切换
Randomized controlled trial study of modified Fangji Dihuang decoction in treating insomnia after endocrine therapy for breast cancer
收藏切换
Yemei LI1, Chuncheng MA2, Qianxing ZHAN1
World Clinical Drug | 2022, 43(4) : 436 - 441
Less
收藏切换
World Clinical Drug | 2022, 43(4): 436-441
• Article •
Randomized controlled trial study of modified Fangji Dihuang decoction in treating insomnia after endocrine therapy for breast cancer
Full
Yemei LI1, Chuncheng MA2, Qianxing ZHAN1
Affiliations
  • 1.Tumor Comprehensive Ward, Wuyi Hospital of Traditional Chinese Medicine, Jiangmen 529000, Guangdong Province, China
  • 2.Department of Infection, Wuyi Hospital of Traditional Chinese Medicine, Jiangmen 529000, Guangdong Province, China
Published: 2022-04-10 doi: 10.13683/j.wph.2022.04.013
Outline
收藏切换
Objective

To investigate the effect of modified Fangji Dihuang decoction on insomnia after endocrine therapy for breast cancer.

Methods

A prospective randomized controlled study (RCT) method was used, a total of 68 female patients with breast cancer who had insomnia after endocrine therapy in Jiangmen Wuyi hospital of Traditional Chinese Medicine of Guangdong from January 2020 to February 2021 were randomly divided into control group (n=34) and treatment group (n=34), the alprazolam and modified Fangji Dihuang decoction were applied respectively, for 14 days. The efficacy, traditional Chinese medicine (TCM) syndrome score, Pittsburgh sleep quality index (PSQI) score, serum neurotransmitter level and medication adverse reactions were compared between the two groups.

Results

The total effective rate of treatment in the treatment group was significantly higher than that in the control group (P<0.05). After 14 days of treatment, TCM syndrome score, PSQI score and serum dopamine level in treatment group were lower than those before treatment and control group at the same time (P<0.05), and serum 5-hydroxytryptamine level was higher than those before treatment and control group at the same time (P<0.05). The incidence of adverse reactions in the treatment group was lower than that in control group (P<0.05).

Conclusion

The effect of modified Fangji Dihuang decoction on insomnia patients after endocrine therapy of breast cancer is better, which can effectively regulate the level of serum neurotransmitter, significantly improve the symptoms of TCM and sleep status, and the safety of medication is high.

Fangji Dihuang decoction  /  breast cancer  /  endocrine therapy  /  insomnia  /  sleep status
李叶枚, 马春成, 詹前兴. 加减防己地黄汤治疗乳腺癌内分泌治疗后失眠的随机对照试验研究. 世界临床药物, 2022 , 43 (4) : 436 -441 . DOI: 10.13683/j.wph.2022.04.013
Yemei LI, Chuncheng MA, Qianxing ZHAN. Randomized controlled trial study of modified Fangji Dihuang decoction in treating insomnia after endocrine therapy for breast cancer[J]. World Clinical Drug, 2022 , 43 (4) : 436 -441 . DOI: 10.13683/j.wph.2022.04.013
Year 2022 volume 43 Issue 4
12
2
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2022.04.013
  • Receive Date:2021-12-02
  • Online Date:2026-11-19
  • Published:2022-04-10
Article Data
Affiliations
History
  • Received:2021-12-02
Funding
Affiliations
    1.Tumor Comprehensive Ward, Wuyi Hospital of Traditional Chinese Medicine, Jiangmen 529000, Guangdong Province, China
    2.Department of Infection, Wuyi Hospital of Traditional Chinese Medicine, Jiangmen 529000, Guangdong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2022.04.013
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT